Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.46 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29956901 | 0.87 | KDM4E (0.59) | PKMHTTPOLBAKR1C3AKR1C2 | |
| SCHEMBL29955411 | 0.87 | CSNK2A1 (0.59) | PKMHTTAKR1C3AKR1C2 | |
| SCHEMBL1162134 | 0.87 | KDM4E (0.59) | PKMHTTPOLBAKR1C3AKR1C2 | |
| SCHEMBL458033 | 0.87 | CSNK2A1 (0.59) | PKMHTTAKR1C3AKR1C2 | |
| SCHEMBL12040090 | 0.85 | MAPT (0.44) | PKMHTTPOLBHSD17B1MAPT | |
| SCHEMBL3183606 | 0.85 | PKM (0.52) | PKMHTTPOLBHSD17B1AKR1C3 | |
| SCHEMBL29803190 | 0.85 | PKM (0.52) | PKMHTTPOLBHSD17B1AKR1C3 | |
| SCHEMBL322274 | 0.85 | PKM (0.52) | PKMHTTPOLBHSD17B1AKR1C3 | |
| Potassium Ion SCHEMBL22689254 | 0.84 | CA1 (0.42) | PKMHTTPOLBHSD17B1MAPT | |
| SCHEMBL3183624 | 0.84 | PKM (0.50) | PKMHTTPOLBHSD17B1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129526-B1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-08-07 | — | — | EP | claimed |
| CN-106460182-B | The method of bath compositions and the electroless for palladium | 安美特德国有限公司 | 2019-07-09 | — | — | CN | claimed |
| US-9758874-B2 | Plating bath composition and method for electroless plating of palladium | ATOTECH DEUTSCHLAND GMBH (DE) | 2017-09-12 | — | — | US | claimed |
| US-20170121823-A1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2017-05-04 | — | — | US | claimed |
| CN-106460182-A | Plating bath composition and method for electroless plating of palladium | 安美特德国有限公司 | 2017-02-22 | — | — | CN | claimed |
| EP-3129526-A1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH Deutschland GmbH (DE) | 2017-02-15 | — | — | EP | claimed |
| CN-109415304-B | Method for producing iron complex and method for producing ester compound using iron complex | 株式会社可乐丽 | 2022-07-22 | — | — | CN | disclosed |
| EP-3476828-B1 | METHOD FOR PRODUCING IRON COMPLEXES AND METHOD FOR PRODUCING ESTER COMPOUNDS USING IRON COMPLEX | KURARAY CO (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-10646859-B2 | Method for producing iron complexes and method for producing ester compounds using iron complex | KURARAY CO., LTD. (JP) | 2020-05-12 | — | — | US | disclosed |
| US-20190351401-A1 | METHOD FOR PRODUCING IRON COMPLEXES AND METHOD FOR PRODUCING ESTER COMPOUNDS USING IRON COMPLEX | KURARAY CO., LTD (JP) | 2019-11-21 | — | — | US | disclosed |
| EP-3129526-B1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-08-07 | — | — | EP | disclosed |
| CN-106460182-B | The method of bath compositions and the electroless for palladium | 安美特德国有限公司 | 2019-07-09 | — | — | CN | disclosed |
| EP-3476828-A1 | METHOD FOR PRODUCING IRON COMPLEX AND METHOD FOR PRODUCING ESTER COMPOUND USING IRON COMPLEX | Kuraray Co., Ltd. (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-20120264731-A1 | CHROMENONE DERIVATIVES | ASTRAZENECA AB (SE) | 2012-10-18 | — | — | US | disclosed |
| US-7799913-B2 | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses | CORTEX PHARMACEUTICALS, INC. (US) | 2010-09-21 | — | — | US | disclosed |
| US-20090036537-A1 | AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-02-05 | — | — | US | disclosed |
| US-7348335-B2 | Compositions useful as inhibitors of JAK and other protein kinases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-03-25 | — | — | US | disclosed |
| US-5629406-A | AMINO ACID DERIVATIVES | SANKYO COMPANY, LIMITED (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0587311-A1 | Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
| EP-0052280-A1 | Process for the production of 3-amino-4,6-diacetyl phenol or a derivative thereof | FISONS plc (GB) | 1982-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190351401-A1 | METHOD FOR PRODUCING IRON COMPLEXES AND METHOD FOR PRODUCING ESTER COMPOUNDS USING IRON COMPLEX | FECH, FTH1, TFRC | PKM 731/4885HTT 4617/4885POLB 2060/4885 |
| US-20120264731-A1 | CHROMENONE DERIVATIVES | RB1, CYP11B1, CCND1 | PKM 989/4885HTT 1878/4885POLB 2169/4885 |
| US-20090036537-A1 | AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES | TRPV5, TRPC5, TRPM5 | PKM 3266/4885HTT 706/4885POLB 3895/4885 |
| US-10646859-B2 | Method for producing iron complexes and method for producing ester compounds using iron complex | FECH, FTH1, TFRC | PKM 731/4885HTT 4617/4885POLB 2060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.